A resolution supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".
- Bill Number
- S.Res. 669
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Passed Senate
- Latest Action
- 2026-04-14: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1745; text: CR S1744)
- Last Updated
- 2026-04-17T18:35:43Z
AI-Generated Summary
Summary of S. Res. 669 (119th Congress)
Purpose
This Senate resolution expresses support for the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month" (designated as March) to raise public awareness about these serious but often preventable blood clot conditions.
Key Provisions
- Background Facts (Preamble):
- Defines deep vein thrombosis (DVT) as a blood clot in deep veins (commonly legs, but also arms, abdomen, or brain).
- Describes pulmonary embolism (PE) as a life-threatening complication where a clot travels to the lungs.
- Notes prevalence: Affects ~900,000 Americans yearly; kills 60,000–100,000 annually (1 in 4 PE deaths sudden).
- Highlights preventability, especially in hospitals; higher risks for cancer patients, pregnant/postpartum women (up to 3 months after birth), immobile people, surgery patients, elderly, and those with family clotting history.
- Cites economic impact: Up to $10 billion in extra medical costs yearly.
- Resolution Actions:
- Supports the goals and ideals of the Awareness Month.
- Recognizes the importance of educating the public about DVT and PE.
Significant Changes to Existing Law
None. This is a non-binding sense of the Senate resolution with no legal force or amendments to statutes.
Potential Impacts
- Citizens: Increased public awareness may encourage prevention (e.g., mobility during travel/surgery) and early detection, potentially reducing preventable deaths.
- Government Agencies: Symbolic endorsement; may indirectly support health agencies like CDC in awareness campaigns, but no funding or mandates.
- International Relations: None.
Main Stakeholders Affected
- At-risk individuals: Cancer patients, pregnant/postpartum women, elderly, surgery patients, immobile people, and those with clotting family history.
- Healthcare providers and hospitals: Encourages focus on preventable hospital deaths.
- Public health organizations: Benefits groups promoting DVT/PE awareness.
- General public: Gains education on symptoms, risks, and prevention.
Notable Legal, Constitutional, or Political Implications
- Purely symbolic; no enforceable obligations or legal changes.
- Bipartisan support (sponsors: Sens. Grassley, Blunt Rochester, Marshall, Lujan); agreed to by Senate on April 14, 2026.
- Reinforces congressional role in public health advocacy without constitutional issues.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Sen. Blunt Rochester, Lisa [D-DE], Sen. Marshall, Roger [R-KS], Sen. Luján, Ben Ray [D-NM]
Recent Actions
- 2026-04-14: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1745; text: CR S1744)
- 2026-04-14: Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Bill Versions
- Supporting the goals and ideals of Deep Vein Thrombosis and Pulmonary Embolism Awareness Month. — issued 2026-04-14 — PDF (3 pages)